NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
record initialized not assigned to examiner
on 29 Jul 2024
Last Applicant/ Owned by
Gridiron Building, 1 Pancras Sq.
London
GB
N1C4AG
Serial Number
98670890 filed on 29th Jul 2024
Registration Number
N/A
Correspondent Address
Brendan J. Hughes
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
EPYQ
Laboratory research in the field of gene expression; Biological cloning services. Nucleic recombinant acids; Proteins for use in recombinant DNA technology [other than for medical use]; Nucleic acid amplification reagents [other than for medical use]; Nucleic acid for use in nucleic acid amplification processes [other than for medical use]; Nucleic acids. Nucleic acid sequences for medical and v Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Laboratory research in the field of gene expression; Biological cloning services.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [009]
Computer & Software Products & Electrical & Scientific Products
Gene amplifiers; DNA microarray; DNA microarrays.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Nucleic acid sequences for medical and veterinary purposes.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Nucleic recombinant acids; Proteins for use in recombinant DNA technology [other than for medical use]; Nucleic acid amplification reagents [other than for medical use]; Nucleic acid for use in nucleic acid amplification processes [other than for medical use]; Nucleic acids.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98670890
Mark Type
No Service Mark
Attorney Docket Number
No 345020-20007
44D Filed
Yes
44D Current
Yes
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 29th Jul 2024 | NEW APPLICATION ENTERED |